Overview
Neuros Medical is developing the HFAC (High-Frequency Alternating Current) Nerve Block technology to treat chronic post-amputation pain through a minimally invasive implantable device that blocks pain signals at the peripheral nerve. Their Altius system has received FDA Breakthrough Device Designation and targets one of the most undertreated pain conditions in veterans and amputees.
More in Neuromodulation
Latest industry news
BlueWind Medical's Revi Extend Wins FDA Clearance, Extending Implant Life to 15 Years
2026-08-06 · Product
Neurofeedback Systems Market Eyes $2.95 Billion Valuation by 2035 as Clinical and Consumer Demand Converge
2026-08-05 · Industry
Smaller Neuromodulation Devices Are Reshaping the Competitive Landscape for TMS Providers
2026-08-04 · Industry
NIH-Backed Brain-Computer Device Restores Speech in Paralyzed Patient
2026-08-03 · Research
Company details
Category
⚡ Neuromodulation
Location
Cleveland, OH, USA
Funding
Series C · $50M+
Website
neurosmedical.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →